iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionMGB Wealth Management, LLC
Latest Disclosed Ownership2,200 shares
Latest Disclosed Value $ 371,346
MGB Wealth Management, LLC ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On February 17, 2026 - MGB Wealth Management, LLC filed a 13F-HR form disclosing ownership of 2,200 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $371,346 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 2,200 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $288,310 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,200 0 0.00 371 17.03 0.1062
2025-11-12 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,200 0 0.00 318 14.03 0.0897
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,200 0 0.00 278 -1.07 0.0917
2025-05-09 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,200 -600 -21.43 281 -23.85 0.1018
2025-01-29 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,800 -1,604 -36.42 370 -42.34 0.1148
2024-11-12 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,404 -1 -0.02 641 0.31 0.2323
2024-08-12 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,405 0 0.00 638 5.63 0.2386
2024-05-06 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,405 0 0.00 605 0.83 0.2457
2024-04-23 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,405 4,405 599 0.3010
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.